Further effort is needed to avoid irrational use after drug susceptibility testing for drug-resistant TB

Affiliations

• ¹ The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe;, Division of Infectious Diseases and Tropical Medicine, Ludwig Maximilian University Hospital, Munich, Germany.
• ² Institute of Microbiology & Laboratory Medicine, IML red, WHO - Supranational Tuberculosis Reference Laboratory, Gauting, Germany.
• ³ Republican Tuberculosis Centre, National Tuberculosis Project Management, Bishkek, Kyrgyz Republic;, National Tuberculosis Reference Laboratory, Bishkek, Kyrgyz Republic.
• ⁴ Bureau for Global Health, TB Division, US Agency for International Development, Washington, DC, USA.
• ⁵ National Tuberculosis Reference Laboratory, Bishkek, Kyrgyz Republic.
• ⁶ Republican Tuberculosis Centre, National Tuberculosis Project Management, Bishkek, Kyrgyz Republic.
• ⁷ The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe;, Division of Infectious Diseases and Tropical Medicine, Ludwig Maximilian University Hospital, Munich, Germany;, Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
• ⁸ Institute of Microbiology & Laboratory Medicine, IML red, WHO - Supranational Tuberculosis Reference Laboratory, Gauting, Germany;, SYNLAB Gauting, SYNLAB MVZ Dachau, Munich-Gauting, Germany.